BASF stock faces renewed Sell call as valuation risk stays in focus

Published on 09/13/2026 at 14:47 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

BASF stock is under pressure after JP Morgan reaffirmed its Sell rating on September 13, 2026, citing valuation concerns and sector risks. The shares remain below their one-year high, while consensus still points to modest upside for the chemical group.

Luftaufnahme eines Chemiewerks bei Nacht mit leuchtendem Rohrnetz, Destillationskolonnen und Fackeln — Cinematische Drohnenaufnahme eines weitläufigen Petrochemie-Komplexes bei Nacht aus ca. 300 Metern Höhe. Hunderte beleuchteter Rohrleitungen, Destillationskolonnen und Reaktortürme bilden ein leuchtendes Gitternetz. Bernsteinfarbene, weiß-blaue Industrielichter spiegeln sich auf dem Boden und in Dampfwolken. Anamorphe Linsenoptik, kinematisches Teal-Shadow-Grading, Illustration mit AI erstellt.

BASF stock (ISIN DE000BASF111) is back in the spotlight after JP Morgan reaffirmed its Sell rating on the shares on September 13, 2026, highlighting valuation risks despite a stabilizing backdrop for chemicals. According to The Globe and Mail on September 13, 2026, JP Morgan maintained its negative stance while noting that the shares recently closed at 51.83 euros and remain below their one-year high of 55.05 euros.

Analyst views split on BASF valuation

The renewed Sell rating by JP Morgan comes against a more constructive broader analyst backdrop for BASF. As The Globe and Mail reports, the current analyst consensus on BASF is rated as Moderate Buy with an average price target of 55.50 euros, which implies around 7.1 percent upside versus the recent close at 51.83 euros.

In the same overview, The Globe and Mail notes that JP Morgan’s Sell call stands in contrast to peers who expect modest gains, underlining how divided the market remains on the stock after a year in which the share price moved between a low of 41.48 euros and a high of 55.05 euros. For investors, this spread between bearish and moderately positive views is central to the current investment debate.

Chemicals sector recovery supports backdrop

The sector context helps explain why many analysts still see upside in BASF despite JP Morgan’s cautious stance. A broad review of the chemical industry’s 2026 performance highlights a clear recovery in volumes and profits in the first half of the year. According to Sina Finance in its sector study for the first half of 2026, the wider chemical industry generated 14,731.1 billion yuan in revenue, up 13.8 percent year on year, while attributable net profit rose 38.6 percent to 1,066.8 billion yuan.

For the second quarter of 2026 alone, Sina Finance reports that revenue in the chemicals sector reached 7,874.0 billion yuan, an increase of 16.7 percent compared with the prior-year quarter, while attributable net profit climbed 57.1 percent to 618.3 billion yuan, with profit growth accelerating versus the first quarter. This backdrop of double-digit revenue growth and even faster profit expansion in the chemicals space provides a tailwind for diversified players such as BASF, which benefit from cyclical volume recovery alongside higher contribution from specialty and new materials businesses.

Risk factors: valuation and cycle sensitivity

Against this improving industry picture, the core risk highlighted by JP Morgan is valuation relative to cyclical exposure. As The Globe and Mail summarizes, the bank argues that BASF’s valuation leaves limited buffer if macro conditions or chemical prices soften again, and therefore continues to justify a Sell recommendation even though the share is trading below its one-year high by around 3.9 euros.

The sector analysis by Sina Finance also points out that the current investment logic in chemicals rests on a mix of cyclical elasticity and technology-driven growth. For highly diversified groups such as BASF, that means exposure to both commodity cycles and structurally growing areas like battery materials, catalysts and specialty polymers. The report stresses that while cyclical recovery offers a margin of safety, investors must still factor in volatility in feedstock costs and potential demand swings, which align with JP Morgan’s caution on valuation risk.

BASF share price and trading context

In terms of market performance, BASF’s shares recently closed at 51.83 euros on their primary listing on the Xetra platform, per closing data referenced by The Globe and Mail. With a one-year high of 55.05 euros and a one-year low of 41.48 euros, the stock currently trades around 6 percent below the high and roughly 25 percent above the low, reflecting a recovery from last year’s trough but still leaving some distance to the upper end of its recent range.

Average daily trading volume for BASF stands at 1.91 million shares according to the same analyst overview from The Globe and Mail, underlining that the stock is highly liquid and reacts quickly to changes in sentiment around the chemicals cycle and European industrial demand. For investors, the combination of a high-liquidity large-cap profile and meaningful cyclical sensitivity means that both macro data and sector reports can move the share price in relatively short order.

Stock remains below high despite sector tailwind

Overall, BASF stock is currently trading below its one-year high even as the chemicals sector posts robust top-line and bottom-line growth. The double-digit 16.7 percent year-on-year increase in sector revenue and the 57.1 percent surge in second-quarter net profit reported by Sina Finance provide a supportive backdrop, but JP Morgan’s reiterated Sell stance, as highlighted by The Globe and Mail, underscores that valuation and cycle risks remain front and center for the stock.